Out of 20 organs, a statistically significant difference in FNDC3B expression in cancer tissues was observed in 17 organs as compared to normal tissues, and no such difference was observed in the thyroid, ureter, and bladder cancers (Figure 1a, Table 1). This evidence concerns the gene FNDC3B and urinary bladder cancer.